Patents expiring in 2030

US 7696246

Bicyclic androgen and progesterone receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7696218

Substituted 1,3-dialkyl-2,4-dioxo-6-(arylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

Takeda San Diego, Inc. · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7696159

Treatment for basal cell carcinoma

Graceway Pharmaceuticals. LLC · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7696151

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7695627

Tangential flow filtration devices and methods for leukocyte enrichment

Northwest Biotherapeutics, Inc. · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7696201

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700128

Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

Takeda Pharmaceutical Company Limited · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700655

Antiallergic agents

Institute of Medicinal Molecular Design, Inc. · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700777

Crystalline forms of a biphenyl compound

Theravance, Inc. · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700738

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700651

Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

The Board of Regents of the University of Texas System · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700641

Spiro-oxindole compounds and their uses as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700609

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700361

Secretory or membrane protein expressed in skeletal muscles

Takeda Pharmaceutical Company Limited · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700578

Capsule composition for use as immunogen against Campylobacter jejuni

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700600

Methods for treating cardiac arrhythmia

The United States of America · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700547

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700127

Method and compositions for preparing and delivering rumen protected lipids, other nutrients and medicaments

The Regents of the University of California · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700273

Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human immunodeficiency virus (HIV) CCR5 coreceptor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700134

Prevention of cisplatin induced deafness

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700274

Compositions and methods in cancer associated with altered expression of KCNJ9

Sagres Discovery, Inc. · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700550

Glycopeptide phosphonate derivatives

Theravance, Inc. · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7705031

Benzimidazoles useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7705164

Metalloprotein inhibitors

The Regents of the University of California · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704500

Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704510

Cytomegalovirus surface protein complex for use in vaccines and as a drug target

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7705188

Structural modification of resveratrol: sodium resverastatin phosphate

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704947

Methods and compositions for the treatment of gastrointestinal disorders

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7705177

Ketone compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7705139

Zinc finger proteins for DNA binding and gene regulation in plants

Sangamo Biosciences, Inc. · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704962

Small oligonucleotides with anti-tumor activity

The Board of Regents of the University of Texas System · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704491

Recombinant human metapneumovirus and its use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704985

Treatment of irritable bowel syndrome and related bowel diseases

The Board of Regents of the University of Texas System · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704976

Use of N-acetyl-D-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention

Third Military Medical University, Chinese People's Liberation Army, P.R. of China · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7705002

Biaryls useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704701

Diagnosis of prostate cancer with SPAS-1 cancer antigen

The Regents of the University of California · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704542

Vitamin/mineral compositions with DHA

Xanodyne Pharmaceuticals, Inc. · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704527

Modified release compositions of milnacipran

Collegium Pharmaceutical, Inc. · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704558

Cleaning article containing hydrophilic polymers

ReGenesis Group · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704509

Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

The United States of America · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7704497

Molecules with extended half-lives, compositions and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7709609

Tumor suppressor gene, p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7709517

Diarylhydantoin compounds

The Regents of the University of California · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7709643

Synthesis of sodium narcistatin and related compounds

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7709493

4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

LEXICON PHARMACEUTICALS, INC. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7709515

Compositions comprising ether compounds and pharmaceutical uses therefor

Esperion Therapeutics, Inc. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7709257

Models for vaccine assessment

VaxDesign Corp. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7709443

Cyclic peptide antitumor agents

Northwestern University · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)